News & Updates
Filter by Specialty:
Ticagrelor after abbreviated DAPT minimizes bleeding while preserving efficacy in ACS
Monotherapy with ticagrelor after a month-long course of dual antiplatelet (DAPT) with ticagrelor plus aspirin works to reduce the risk of bleeding without compromising ischaemic outcomes among patients with acute coronary syndrome (ACS) as compared with guideline-recommended treatment with 12-month DAPT followed by aspirin monotherapy, according to data from the GLOBAL LEADERS trial.
Ticagrelor after abbreviated DAPT minimizes bleeding while preserving efficacy in ACS
12 Oct 2021
Mild cognitive impairment common in hypertensive patients
Mild cognitive impairment (MCI) is common among patients with hypertension, reports a recent meta-analysis. Early screening is needed in this population to facilitate timely intervention.
Mild cognitive impairment common in hypertensive patients
12 Oct 2021
Aspirin slows down metabolic clock of gestation, reduces risk of pre-eclampsia
Recent research by the Chinese University of Hong Kong (CUHK) and Baylor College of Medicine discovers that aspirin’s benefit in preventing pre-eclampsia is mediated through decelerating the metabolic clock of gestation.
Aspirin slows down metabolic clock of gestation, reduces risk of pre-eclampsia
12 Oct 2021
Diet plus exercise keeps BP in check for patients with resistant hypertension
A structured lifestyle modification programme that combines a healthy eating plan and regular aerobic exercise promotes blood pressure (BP) control and improves cardiovascular disease biomarkers in patients with resistant hypertension, as shown in the TRIUMPH study.
Diet plus exercise keeps BP in check for patients with resistant hypertension
11 Oct 2021
Continuous vital sign monitoring catches COVID-19 deterioration early
A wearable chest patch device can continuously monitor vital signs in patients with the coronavirus disease 2019 (COVID-19), facilitating the early detection of cardiovascular deterioration, according to a recent study.
Continuous vital sign monitoring catches COVID-19 deterioration early
11 Oct 2021
CV risk remains elevated in metabolically healthy obese
Individuals who are obese but without metabolic abnormalities (metabolically healthy obese [MHO]) have an elevated risk of developing MACE-HF*, new-onset heart failure (HF), and new-onset atrial fibrillation (AF), according to a French study presented at EASD 2021.
CV risk remains elevated in metabolically healthy obese
08 Oct 2021
Noncardiac surgery after stenting ups myocardial infarction risk in ACS, SAP patients
In patients with acute coronary syndrome (ACS) or stable angina pectoris (SAP), undergoing noncardiac surgery after stenting increases the risk of myocardial infarction (MI), but only when procedures are performed during acute admission, a recent study has found.